A PHASE 2 TRIAL OF SALVAGE TREATMENT WITH GEMCITABINE AND S-1 COMBINATION IN HEAVILY PRETREATED PATIENTS WITH METASTATIC COLORECTAL CANCER

被引：0
|
作者：
Sym, S. J. [1 ]
Hong, J. [1 ]
Ahn, H. K. [1 ]
Park, J. [1 ]
Cho, E. K. [1 ]
Lee, J. H. [1 ]
Lee, W. [2 ]
Baek, J. [2 ]
Park, Y. H. [2 ]
Shin, D. B. [1 ]
机构：
[1] Gachon Univ, Gil Hosp, Dept Internal Med, Div Hematol & Oncol, Inchon, South Korea
[2] Gachon Univ, Gil Hosp, Dept Gen Surg, Inchon, South Korea
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
10.1016/S0959-8049(13)70005-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AOSOP5
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [31] A phase II trial of gemcitabine, S-1 and LV combination therapy in patients with advanced pancreatic cancer
    Saito, K. O.
    Nakai, Y.
    Isayama, H.
    Ishigaki, K.
    Saito, T.
    Takahara, N.
    Mizuno, S.
    Kogure, H.
    Koike, K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [32] Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer
    Nakamura, K
    Yamaguchi, T
    Ishihara, T
    Kobayashi, A
    Tadenuma, H
    Sudo, K
    Kato, H
    Saisho, H
    BRITISH JOURNAL OF CANCER, 2005, 92 (12) : 2134 - 2139
  • [33] Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer
    K Nakamura
    T Yamaguchi
    T Ishihara
    A Kobayashi
    H Tadenuma
    K Sudo
    H Kato
    H Saisho
    British Journal of Cancer, 2005, 92 : 2134 - 2139
  • [34] Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer
    K Nakamura
    T Yamaguchi
    T Ishihara
    K Sudo
    H Kato
    H Saisho
    British Journal of Cancer, 2006, 94 : 1575 - 1579
  • [35] Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer
    Nakamura, K.
    Yamaguchi, T.
    Ishihara, T.
    Sudo, K.
    Kato, H.
    Saisho, H.
    BRITISH JOURNAL OF CANCER, 2006, 94 (11) : 1575 - 1579
  • [36] Irinotecan-Cetuximab-Bevacizumab as a Salvage Treatment in Heavily Pretreated Metastatic Colorectal Cancer Patients: A Retrospective Observational Study
    Feliu Batlle, J.
    Cuadrado, E.
    Castro, J.
    Caldes, T.
    Belda, C.
    Sastre, J.
    Barriuso, J.
    Martinez Marin, V.
    Diaz-Rubio, E.
    Gonzalez-Baron, M.
    CHEMOTHERAPY, 2011, 57 (02) : 138 - 144
  • [37] Phase II trial of S-1 in combination with gemcitabine for chemo-na⟨ve patients with locally advanced or metastatic pancreatic cancer
    Lee, Gyeong-Won
    Kim, Hye Jung
    Ju, Ji-Hyun
    Kim, Seok-Hyun
    Kim, Hoon Gu
    Kim, Tae Hyo
    Kim, Hyun Jin
    Jeong, Chi-Young
    Kang, Jung Hun
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (04) : 707 - 713
  • [38] Phase II trial of S-1 in combination with gemcitabine for chemo-naïve patients with locally advanced or metastatic pancreatic cancer
    Gyeong-Won Lee
    Hye Jung Kim
    Ji-Hyun Ju
    Seok-Hyun Kim
    Hoon Gu Kim
    Tae Hyo Kim
    Hyun Jin Kim
    Chi-Young Jeong
    Jung Hun Kang
    Cancer Chemotherapy and Pharmacology, 2009, 64
  • [39] Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer
    Shin, Sang Joon
    Jeong, Jae Heon
    Park, Young Suk
    Lee, Kyung Hee
    Shim, Byoung Yong
    Kim, Tae Won
    Oh, Do Youn
    Lee, Myung Ah
    Kim, Yong Tai
    Kim, Yeul Hong
    Zang, Dae Young
    Roh, Jae Kyung
    Ahn, Joong Bae
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (05) : 1073 - 1080
  • [40] Phase I trial of oxaliplatin plus S-1 chemotherapy in patients with metastatic colorectal cancer
    Emi, Manabu
    Yamaguchi, Yoshiyuki
    Hihara, Jun
    Hironaka, Katsuji
    Okada, Morihito
    ONCOLOGY LETTERS, 2010, 1 (01) : 95 - 98
12345